Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Jennifer A WoyachAlessandra TedeschiTalha MunirTanya SiddiqiPeter HillmenJohn C ByrdPaolo GhiaStephen P MulliganSandra DaiCarlos I Amaya-ChanagaJames P DeanSusan M O'BrienPaul M BarrPublished in: Leukemia & lymphoma (2021)